What are the major opportunities in the Personalized Cancer Vaccines market? What are the strategies for the Personalized Cancer Vaccines market?

For detailed insights on the major opportunities and strategies in the Personalized Cancer Vaccines market, Read More

How does the Personalized Cancer Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Personalized Cancer Vaccines's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Personalized Cancer Vaccines market growth? SWOT analysis of the Personalized Cancer Vaccines market.

For detailed insights on the key dynamics influencing the Personalized Cancer Vaccines market growth and SWOT analysis of the Personalized Cancer Vaccines industry, Read More

Personalized Cancer Vaccines Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Personalized Cancer Vaccines Market Report 2026

Name: Personalized Cancer Vaccines Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma), By Mechanism Of Action (Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action), By Route Of Administration (Injectables, Other Routes Of Administration), By End Use (Hospitals, Clinic, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Personalized Cancer Vaccines Market Overview

• Personalized Cancer Vaccines market size has reached to $256.65 billion in 2025

• Expected to grow to $350.3 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%

• Growth Driver: Increasing Cancer Incidence Accelerates Demand For Targeted Immunotherapies

• Market Trend: Innovative Therapies Target Specific Cancer Mutations For Enhanced Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Cancer Vaccines Market?

Personalized cancer vaccines refer to treatments tailored to an individual's unique tumor profile, aiming to stimulate their immune system to target and destroy cancer cells. They improve the body's ability to recognize and fight specific cancer types, potentially enhancing treatment efficacy and reducing recurrence.

The main types of personalized cancer vaccines are preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines are designed to protect against infections or conditions that may lead to cancer. It is used to treat various cancer types, including lung cancer, breast cancer, colorectal cancer, leukemia, prostate cancer, cervical cancer, and glioblastoma, through different mechanisms of action, including tumor-associated antigens (TAAS), tumor-specific antigens (TSAS), somatic mutations in cancer pharmacogenomics, pharmacogenomics towards genomic polymorphism, and others. It is provided through varying routes of administration, which include injectables and others in different end uses, such as hospitals, clinics, and others.

Personalized Cancer Vaccines Market Global Report 2026 Market Report bar graph

What Is The Personalized Cancer Vaccines Market Size and Share 2026?

The personalized cancer vaccines market size has grown strongly in recent years. It will grow from $256.65 billion in 2025 to $273.05 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to advances in cancer genomics, unmet need in oncology treatments, limitations of traditional cancer therapies, growth in immunotherapy research, increased funding for cancer research.

What Is The Personalized Cancer Vaccines Market Growth Forecast?

The personalized cancer vaccines market size is expected to see strong growth in the next few years. It will grow to $350.3 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to expansion of personalized medicine adoption, increasing cancer incidence rates, progress in neoantigen discovery, rising collaboration between biotech firms, supportive regulatory frameworks. Major trends in the forecast period include rising focus on personalized immunotherapy, increasing use of genomic tumor profiling, expansion of therapeutic cancer vaccines, growing integration with precision oncology, higher clinical trial activity in cancer vaccines.

Book your 30 minutes free consultation with our research experts

Global Personalized Cancer Vaccines Market Segmentation

1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

4) By Route Of Administration: Injectables, Other Routes Of Administration

5) By End Use: Hospitals, Clinic, Other End Users

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines

2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

What Is The Driver Of The Personalized Cancer Vaccines Market?

The increasing prevalence of cancer is expected to propel the growth of the personalized cancer vaccine market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth that can invade surrounding tissues and spread to other parts of the body. The increasing prevalence of cancer is driven by aging populations, lifestyle changes, environmental exposures, and improved diagnostic capabilities. The personalized cancer vaccine market supports cancer care by delivering vaccines tailored to patient-specific tumor antigens, strengthening the immune system’s ability to identify and eliminate cancer cells. For instance, in July 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, cancer diagnoses in Australia rose from 160,570 cases in 2022 to 164,694 cases in 2023, indicating a significant year-over-year increase. Therefore, the increasing prevalence of cancer is driving the growth of the personalized cancer vaccine industry.

Key Players In The Global Personalized Cancer Vaccines Market

Major companies operating in the personalized cancer vaccines market are Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

Global Personalized Cancer Vaccines Market Trends and Insights

Major companies operating in the personalized cancer vaccine market are focusing on developing advanced therapeutic solutions, such as personalized immunotherapy designed to target patient-specific tumor mutations, to enhance treatment precision and improve clinical outcomes. Personalized immunotherapy refers to customized cancer treatments that use a patient’s own genetic and tumor mutation profile often delivered through dendritic cell–based vaccines or neoantigen-targeted platforms to activate a tailored immune response against malignant cells. For instance, in August 2024, UCLA Health, a US-based healthcare organization, launched a first-of-its-kind clinical trial evaluating a personalized cancer vaccine that targets the H3 G34 mutation in diffuse hemispheric gliomas, using dendritic cells to stimulate immunity against the RNA disruptions caused by this aggressive mutation, offering a promising therapeutic option for adolescents and young adults who typically have limited treatment choices and poor survival rates.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Personalized Cancer Vaccines Market?

In June 2025, BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V., a for an undisclosed amount. With this acquisition, BioNTech aims to strengthen its research, development, manufacturing, and commercialization of mRNA-based cancer immunotherapy, deepening its oncology strategy. CureVac N.V. is a Germany-based Company that developing personalized cancer vaccines.

Regional Insights

North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Cancer Vaccines Market?

The personalized cancer vaccines market consists of sales of patient-specific vaccines, neoantigen-based therapies, dendritic cell-based vaccines and peptide-based immunotherapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Personalized Cancer Vaccines Market Report 2026?

The personalized cancer vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Personalized Cancer Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$273.05 billion
Revenue Forecast In 2035	$350.3 billion
Growth Rate	CAGR of 6.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Cancer Type, Mechanism Of Action, Route Of Administration, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalen
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Personalized Cancer Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Personalized Cancer Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Personalized Cancer Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Personalized Cancer Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Focus On Personalized Immunotherapy

4.2.2 Increasing Use Of Genomic Tumor Profiling

4.2.3 Expansion Of Therapeutic Cancer Vaccines

4.2.4 Growing Integration With Precision Oncology

4.2.5 Higher Clinical Trial Activity In Cancer Vaccines

5. Personalized Cancer Vaccines Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Treatment Centers

5.3 Oncology Clinics

5.4 Research Institutes

5.5 Biotechnology Companies

6. Personalized Cancer Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Cancer Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Personalized Cancer Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Personalized Cancer Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Personalized Cancer Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Personalized Cancer Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Cancer Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Cancer Vaccines Market Segmentation

9.1. Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

9.2. Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

9.3. Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

9.4. Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectables, Other Routes Of Administration

9.5. Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinic, Other End Users

9.6. Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Preventive Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines

9.7. Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Therapeutic Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

10. Personalized Cancer Vaccines Market Regional And Country Analysis

10.1. Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Cancer Vaccines Market

11.1. Asia-Pacific Personalized Cancer Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Cancer Vaccines Market

12.1. China Personalized Cancer Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Cancer Vaccines Market

13.1. India Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Cancer Vaccines Market

14.1. Japan Personalized Cancer Vaccines Market Overview

14.2. Japan Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Cancer Vaccines Market

15.1. Australia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Cancer Vaccines Market

16.1. Indonesia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Cancer Vaccines Market

17.1. South Korea Personalized Cancer Vaccines Market Overview

17.2. South Korea Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Cancer Vaccines Market

18.1. Taiwan Personalized Cancer Vaccines Market Overview

18.2. Taiwan Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Cancer Vaccines Market

19.1. South East Asia Personalized Cancer Vaccines Market Overview

19.2. South East Asia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Cancer Vaccines Market

20.1. Western Europe Personalized Cancer Vaccines Market Overview

20.2. Western Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Cancer Vaccines Market

21.1. UK Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Cancer Vaccines Market

22.1. Germany Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Cancer Vaccines Market

23.1. France Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Cancer Vaccines Market

24.1. Italy Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Cancer Vaccines Market

25.1. Spain Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Cancer Vaccines Market

26.1. Eastern Europe Personalized Cancer Vaccines Market Overview

26.2. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Cancer Vaccines Market

27.1. Russia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Cancer Vaccines Market

28.1. North America Personalized Cancer Vaccines Market Overview

28.2. North America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Cancer Vaccines Market

29.1. USA Personalized Cancer Vaccines Market Overview

29.2. USA Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Cancer Vaccines Market

30.1. Canada Personalized Cancer Vaccines Market Overview

30.2. Canada Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Cancer Vaccines Market

31.1. South America Personalized Cancer Vaccines Market Overview

31.2. South America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Cancer Vaccines Market

32.1. Brazil Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Cancer Vaccines Market

33.1. Middle East Personalized Cancer Vaccines Market Overview

33.2. Middle East Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Cancer Vaccines Market

34.1. Africa Personalized Cancer Vaccines Market Overview

34.2. Africa Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Cancer Vaccines Market Regulatory and Investment Landscape

36. Personalized Cancer Vaccines Market Competitive Landscape And Company Profiles

36.1. Personalized Cancer Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Personalized Cancer Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Personalized Cancer Vaccines Market Company Profiles

36.3.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. CureVac AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Cancer Vaccines Market Other Major And Innovative Companies

GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

38. Global Personalized Cancer Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Cancer Vaccines Market

40. Personalized Cancer Vaccines Market High Potential Countries, Segments and Strategies

40.1 Personalized Cancer Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Personalized Cancer Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Personalized Cancer Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Personalized Cancer Vaccines Market, Overview Of Key Products - Product Examples

Table 2: Global Personalized Cancer Vaccines Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Personalized Cancer Vaccines Market, Supply Chain Analysis

Table 4: Global Personalized Cancer Vaccines Market, Major Raw Material Providers

Table 5: Global Personalized Cancer Vaccines Market, Major Resource Providers

Table 6: Global Personalized Cancer Vaccines Market, Major Manufacturers (Suppliers)

Table 7: Global Personalized Cancer Vaccines Market, Major Distributors And Channel Partners

Table 8: Global Personalized Cancer Vaccines Market, Key Technologies & Future Trends

Table 9: Global Personalized Cancer Vaccines Market, Major Trends

Table 10: Global Personalized Cancer Vaccines Market, Major End Users

Table 11: Global Personalized Cancer Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Personalized Cancer Vaccines Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Personalized Cancer Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Personalized Cancer Vaccines Market - TAM, US$ Billion, 2025

Table 15: Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Preventive Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Therapeutic Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Personalized Cancer Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Personalized Cancer Vaccines Market - Company Scoring Matrix

Table 98: Moderna Inc. Financial Performance

Table 99: CureVac AG Financial Performance

Table 100: BioNTech SE Financial Performance

Table 101: Genentech Inc. Financial Performance

Table 102: Merck & Co. Inc. Financial Performance

Table 103: Global Personalized Cancer Vaccines Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Personalized Cancer Vaccines Market, Competitive Dashboard

Table 105: Global Personalized Cancer Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Personalized Cancer Vaccines Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 107: Global, Personalized Cancer Vaccines Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Table 108: Global, Personalized Cancer Vaccines Market Size Gain ($ Billion), Segmentation By Mechanism Of Action, 2025 – 2030

List Of Figures

Figure 1: Global Personalized Cancer Vaccines Market, Overview Of Key Products - Product Examples

Figure 2: Global Personalized Cancer Vaccines Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Personalized Cancer Vaccines Market, Supply Chain Analysis

Figure 4: Global Personalized Cancer Vaccines Market, Major Raw Material Providers

Figure 5: Global Personalized Cancer Vaccines Market, Major Resource Providers

Figure 6: Global Personalized Cancer Vaccines Market, Major Manufacturers (Suppliers)

Figure 7: Global Personalized Cancer Vaccines Market, Major Distributors And Channel Partners

Figure 8: Global Personalized Cancer Vaccines Market, Key Technologies & Future Trends

Figure 9: Global Personalized Cancer Vaccines Market, Major Trends

Figure 10: Global Personalized Cancer Vaccines Market, Major End Users

Figure 11: Global Personalized Cancer Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Personalized Cancer Vaccines Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Personalized Cancer Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Personalized Cancer Vaccines Market - TAM, US$ Billion, 2025

Figure 15: Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Preventive Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Therapeutic Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Personalized Cancer Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Personalized Cancer Vaccines Market - Company Scoring Matrix

Figure 98: Moderna Inc. Financial Performance

Figure 99: CureVac AG Financial Performance

Figure 100: BioNTech SE Financial Performance

Figure 101: Genentech Inc. Financial Performance

Figure 102: Merck & Co. Inc. Financial Performance

Figure 103: Global Personalized Cancer Vaccines Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Personalized Cancer Vaccines Market, Competitive Dashboard

Figure 105: Global Personalized Cancer Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Personalized Cancer Vaccines Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 107: Global, Personalized Cancer Vaccines Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Figure 108: Global, Personalized Cancer Vaccines Market Size Gain ($ Billion), Segmentation By Mechanism Of Action, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Underwater Drone Market Report 2026 - Global Outlook – By Vehicle Control Mode (Remotely Operated Vehicle, Autonomous Underwater Vehicles, Hybrid Vehicles), By Product Type (Micro, Small And Medium, Light Work-Class, Hea...

Automatic Effluent Samplers Market Report 2026 - Global Outlook – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel (Direct Sales, Distributors), By Application (Industrial Wastewater, Mun...

UV Disinfection Equipment Market Report 2026 - Global Outlook – By Component (UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating (Low, Medium, High ), By Application (Water Trea...

Healthcare Environmental Services Market Report 2026 - Global Outlook – By Type (Janitorial Cleaning Services, Enhanced Cleaning Technology), By Facility Type (Acute Care, Post-Acute-Care, Non-Acute Care), By End User (M...

Reed Switch Device Market Report 2026 - Global Outlook – By Product Type ( Normally Open (A-Type), Normally Closed (B-Type), Changeover (C-Type) ), By Distribution Channel ( Direct Sales, Distributor ), By Application ( ...

Frequently Asked Questions

How big is the Personalized Cancer Vaccines Market?

The Personalized Cancer Vaccines market was valued at $256.65 billion in 2025, increased to $273.05 billion in 2026, and is projected to reach $350.3 billion by 2030.

What is the Personalized Cancer Vaccines market growth?

The global Personalized Cancer Vaccines market is expected to grow at a CAGR of 6.4% from 2026 to 2035 to reach $350.3 billion by 2035.

Who are the key players in Personalized Cancer Vaccines market?

Some Key Players in the Personalized Cancer Vaccines market Include, Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuti

Major trend in this market includes: Innovative Therapies Target Specific Cancer Mutations For Enhanced Treatment. For further insights on this market. request a sample here

North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report

Book your 30 minutes free consultation with our research experts

Contact Us